Stryker Corporation (SYK)
Healthcare · Medical - Devices · Data as of 2026-09-01
Bottom line
SYK is trading near its usual valuation, near its historical resistance zone, and recent volume suggests money flowing out. Historically, this combination has called for extra caution. Past patterns are not a guarantee of future results.
Valuation — Trading near its usual range (Yellow)
SYK trades at 34× earnings, below its own 5-year average of 44× and above similar healthcare companies we track (29×, 52 peers). That is roughly what the market has typically paid for this stock. Its free-cash-flow yield is about 3.7%. Its current multiple sits around the 6th percentile of its own last five years — toward the low end of its own range.
Price zones — Near its historical resistance zone (Red)
At $317.40, the stock is close to the upper end of its recent range. Over the past year SYK has traded between $281.00 and $396.86; its historical support zone sits near $281.00 and resistance near $329.24. It is below both its 50- and 200-day averages, which has historically signalled a downtrend.
52-week range $281.00–$396.86 · 50-day average $329.24 · 200-day average $339.31
Money flow — Money is flowing out (Red)
Recent trading in SYK shows more volume on falling days than rising days, a pattern often described as distribution. Volume on up days has been about 0.9× volume on down days over the last 30 sessions.
About the company
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions.
一句话结论
SYK 估值接近其惯常水平，接近其历史阻力区，近期成交量显示资金正在流出。从历史来看，这样的组合需要格外谨慎。过去的形态并不能保证未来的结果。
估值 — 处于其惯常的估值区间
SYK 目前的市盈率为 34×，低于其自身 5 年平均的 44×，并且高于我们追踪的同类Healthcare公司（29×，52 家）。这大致就是市场以往为这只股票所付出的水平。其自由现金流收益率约为 3.7%。它当前的估值倍数大约位于自身过去五年分布的第 6 百分位——处于自身区间的偏低位置。
价格区间 — 接近其历史阻力区
目前价格为 $317.40，接近其近期区间的上沿。过去一年 SYK 的价格在 $281.00 到 $396.86 之间波动；其历史支撑区在 $281.00 附近，阻力区在 $329.24 附近。它同时位于 50 日和 200 日均线下方，这在历史上通常对应下降趋势。
资金流向 — 资金正在流出
SYK 近期下跌日的成交量高于上涨日，这种形态常被称为派发。过去 30 个交易日，上涨日的成交量约为下跌日的 0.9×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.